Literature DB >> 23486083

Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications.

Emad Kandil1, Barath Krishnan, Salem I Noureldine, Lu Yao, Ralph P Tufano.   

Abstract

BACKGROUND: We sought to determine certain factors predicting postoperative need for hormone replacement therapy (HRT) after hemithyroidectomy.
METHODS: A PubMed search was conducted to identify articles with separate cohorts for total and hemithyroidectomy. Outcomes of interest included hypothyroidism and complications.
RESULTS: Of 50,445 patients, 15,412 (30.6%) underwent hemithyroidectomy. The reported incidence rate of postoperative hypothyroidism was 10.9-48.8%. The pooled mean preoperative thyroid-stimulating hormone (TSH) level was 1.06 µIU/l (0.83-1.29) higher in hypothyroid patients. A preoperative TSH level >2.5 µIU/l was associated with a relative risk (RR, 95% CI) of 3.16 (2.03-4.90) for postoperative hypothyroidism. There was a significant pooled RR of 3.52 (2.55-4.86) for thyroid antibodies and 3.30 (2.49-4.36) for thyroiditis on pathology for postoperative HRT. The pooled RR for postoperative complications was 10.67 (5.75-19.31) for temporary hypocalcemia, 3.17 (1.72-5.83) for permanent hypocalcemia, 1.69 (1.30-2.20) for temporary injury to the recurrent laryngeal nerve (RLN), 1.85 (1.28-2.69) for permanent RLN injury and 2.58 (1.69-3.93) for hemorrhage in patients who underwent total thyroidectomy compared to hemithyroidectomy.
CONCLUSION: Higher preoperative TSH levels, presence of anti-thyroid antibodies and thyroiditis predict postoperative need for HRT. It is imperative to counsel patients with these findings regarding their higher risk of developing postoperative hypothyroidism and need for HRT after hemithyroidectomy.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23486083     DOI: 10.1159/000345498

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  29 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  Surgical management of papillary thyroid carcinoma: an overview.

Authors:  Paolo Miccoli; Sohail Bakkar
Journal:  Updates Surg       Date:  2017-04-12

3.  Perioperative kinetics of parathyroid hormone in unilateral, primary thyroid surgery.

Authors:  Regina Promberger; Johannes Ott; Claudia Bures; Michael Freissmuth; Rudolf Seemann; Michael Hermann
Journal:  Endocrine       Date:  2014-05-25       Impact factor: 3.633

4.  Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

Authors:  Zhe Li; Yuxuan Qiu; Yuan Fei; Zhichao Xing; Jingqiang Zhu; Anping Su
Journal:  Endocrine       Date:  2020-07-07       Impact factor: 3.633

5.  Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis.

Authors:  Kyle A Zanocco; Max M Wang; Michael W Yeh; Masha J Livhits
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

Review 6.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

7.  Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes.

Authors:  Amanda K Price; Reese W Randle; David F Schneider; Rebecca S Sippel; Susan C Pitt
Journal:  J Surg Res       Date:  2017-06-21       Impact factor: 2.192

8.  Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.

Authors:  Alan Zambeli-Ljepović; Frances Wang; Michaela A Dinan; Terry Hyslop; Michael T Stang; Sanziana A Roman; Julie A Sosa; Randall P Scheri
Journal:  Surgery       Date:  2019-07-06       Impact factor: 3.982

9.  Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?

Authors:  Victoria Harries; Laura Y Wang; Marlena McGill; Bin Xu; R Michael Tuttle; Richard J Wong; Ashok R Shaha; Jatin P Shah; Ronald Ghossein; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2019-09-09       Impact factor: 3.982

10.  Efficacy of apparent diffusion coefficient in predicting aggressive histological features of papillary thyroid carcinoma.

Authors:  Bin Song; Hao Wang; Yongqi Chen; Weiyan Liu; Ran Wei; Yi Ding
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.